Bailard’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$550K Hold
33,300
0.01% 492
2026
Q1
$542K Hold
33,300
0.01% 464
2025
Q4
$495K Hold
33,300
0.01% 470
2025
Q3
$428K Buy
33,300
+7,700
+30% +$103K 0.01% 527
2025
Q2
$389K Sell
25,600
-300
-1% -$4.68K 0.01% 548
2025
Q1
$433K Sell
25,900
-9,541
-27% -$176K 0.01% 490
2024
Q4
$668K Buy
+35,441
New +$683K 0.02% 400
2024
Q3
Sell
-10,765
Closed -$203K 801
2024
Q2
$203K Sell
10,765
-7,424
-41% -$127K 0.01% 683
2024
Q1
$295K Buy
+18,189
New +$266K 0.01% 569
2022
Q2
Sell
-34,707
Closed -$449K 780
2022
Q1
$449K Sell
34,707
-4,083
-11% -$53.9K 0.02% 423
2021
Q4
$614K Buy
38,790
+3,526
+10% +$60.2K 0.02% 367
2021
Q3
$687K Hold
35,264
0.02% 341
2021
Q2
$803K Hold
35,264
0.03% 310
2021
Q1
$648K Hold
35,264
0.02% 332
2020
Q4
$526K Buy
35,264
+5,568
+19% +$72.7K 0.02% 317
2020
Q3
$333K Buy
+29,696
New +$292K 0.02% 361
2020
Q1
Sell
-34,934
Closed -$439K 557
2019
Q4
$439K Sell
34,934
-10,208
-23% -$110K 0.02% 314
2019
Q3
$403K Sell
45,142
-3,155
-7% -$27.6K 0.02% 322
2019
Q2
$413K Buy
+48,297
New +$382K 0.03% 332

Other funds holding SEM

Bailard's SEM Position: Q2 2026 in Review

Bailard held its Select Medical (SEM) position steady in Q2 2026 at 33,300 shares worth $550K. The position accounts for 0.01% of the portfolio, ranked #492.

Bailard first reported a position in SEM in Q2 2019 and has held it in 19 quarters since. The position peaked at $803K in Q2 2021. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Bailard held 33,300 shares of Select Medical worth $550K as of Q2 2026.
  • Bailard left its Select Medical share count unchanged in Q2 2026.
  • Select Medical made up 0.01% of Bailard's portfolio in Q2 2026, its #492 holding.
  • Bailard first reported a position in Select Medical in Q2 2019 and has held it in 19 quarters since.
  • Bailard's Select Medical position peaked at $803K in Q2 2021.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.